CDT — CONDUIT PHARMACEUTICALS INC
As of Q2 2026, 2 SEC-registered investment managers reported holding CDT (CONDUIT PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $27.46K across 49.03K shares. That is +2451600.0% by share count (+49.03K shares) versus the previous quarter, while reported value moved +274480.0%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 2 opened new positions, 1 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
CDT is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| AQR Capital Management history | Q1 2025 | 111.36K | $86.97K | 0.00% | Reduce |
| Marshall Wace history | Q2 2024 | 59.73K | $63.31K | 0.00% | Reduce |
| Renaissance Technologies history | Q2 2024 | 26.00K | $27.56K | 0.00% | New |
| Vanguard Group history | Q4 2024 | 366.70K | $25.30K | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 32.30K | $18.09K | 0.00% | New |
| Northern Trust Corp history | Q4 2024 | 186.18K | $12.77K | 0.00% | Add |
| Fidelity Management & Research (FMR) history | Q2 2025 | 4.53K | $12.49K | 0.00% | Reduce |
| Goldman Sachs Group history | Q1 2025 | 12.57K | $9.82K | 0.00% | Reduce |
| Geode Capital Management history | Q2 2026 | 16.74K | $9.37K | 0.00% | New |
| Charles Schwab Investment Management history | Q4 2024 | 53.11K | $3.64K | 0.00% | Hold |
| Two Sigma Investments history | Q4 2024 | 27.91K | $1.92K | 0.00% | New |
| Invesco Ltd history | Q4 2024 | 12.88K | $883 | 0.00% | Add |
| UBS Group AG history | Q4 2025 | 635 | $813 | 0.00% | Reduce |
| Deutsche Bank AG history | Q2 2025 | 294 | $811 | 0.00% | New |
| JPMorgan Chase & Co history | Q1 2025 | 843 | $659 | 0.00% | Reduce |
| Citigroup Inc history | Q1 2025 | 516 | $403 | 0.00% | Reduce |
| Wells Fargo & Co history | Q2 2025 | 10 | $28 | 0.00% | Reduce |
| Bank of America Corp history | Q4 2025 | 11 | $14 | 0.00% | Reduce |
| BlackRock Inc history | Q4 2025 | 9 | $12 | 0.00% | Reduce |
| Morgan Stanley history | Q1 2026 | 2 | $10 | 0.00% | Reduce |
New Positions (Q2 2026)
- Citadel Advisors 32.30K sh · $18.09K
- Geode Capital Management 16.74K sh · $9.37K
Fully Exited (vs previous quarter)
- Morgan Stanley sold 2 sh · $10
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | — | 16.57K | — | — | 189.99K | 526.27K | — | — | 35.61K | — | — | 32.30K |
| Geode Capital Management | — | 139.64K | 138.94K | 409.43K | 427.68K | 584.98K | 18.64K | — | — | — | — | 16.74K |
| BlackRock Inc | — | — | — | — | 755.61K | 539.74K | 4.33K | 74 | 74 | 9 | — | — |
| Morgan Stanley | 25 | — | 11.79K | 56.73K | 183.58K | 261.51K | 12.37K | 226 | 87 | 11 | 2 | — |
| Bank of America Corp | — | 557 | 8.00K | 11.47K | 17.91K | 42.70K | 360 | 326 | 22 | 11 | — | — |
| UBS Group AG | 3.83K | — | 41 | 17.32K | 168.59K | 29.72K | 79.71K | 13.22K | 15.64K | 635 | — | — |
| Fidelity Management & Research (FMR) | — | — | — | — | 20.34K | 170.90K | 17.15K | 4.53K | — | — | — | — |
| JPMorgan Chase & Co | — | 6.41K | 26.83K | 9.82K | 21.88K | 176.37K | 843 | — | — | — | — | — |
| Goldman Sachs Group | — | — | 68.55K | 20.07K | 50.72K | 260.76K | 12.57K | — | — | — | — | — |
| Deutsche Bank AG | — | — | — | — | — | — | — | 294 | — | — | — | — |
| Renaissance Technologies | — | — | — | 26.00K | — | — | — | — | — | — | — | — |
| Two Sigma Investments | — | — | — | — | — | 27.91K | — | — | — | — | — | — |
| AQR Capital Management | — | — | — | — | 33.10K | 123.43K | 111.36K | — | — | — | — | — |
| Citigroup Inc | — | — | — | 5.41K | 16.69K | 44.85K | 516 | — | — | — | — | — |
| Invesco Ltd | — | — | — | 48.14K | 10.76K | 12.88K | — | — | — | — | — | — |
| Marshall Wace | — | — | 61.95K | 59.73K | — | — | — | — | — | — | — | — |
| Northern Trust Corp | — | 21.18K | 21.79K | 29.81K | 184.84K | 186.18K | — | — | — | — | — | — |
| Charles Schwab Investment Management | — | — | — | 53.11K | 53.11K | 53.11K | — | — | — | — | — | — |
| Vanguard Group | — | 236.26K | 207.89K | 341.43K | 361.71K | 366.70K | — | — | — | — | — | — |
| Wells Fargo & Co | — | 72 | 75 | 8.46K | 8.47K | 29.17K | 387 | 10 | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details